Live Breaking News & Updates on Roivant sciences stock performance

Stay informed with the latest breaking news from Roivant sciences stock performance on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Roivant sciences stock performance and stay connected to the pulse of your community

Roivant Sciences (NASDAQ:ROIV) Rating Reiterated by HC Wainwright

Roivant Sciences (NASDAQ:ROIV) Rating Reiterated by HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Piper-sandler , Eric-venker , Roivant-sciences , Analyst-recommendations-for-roivant-sciences , Roivant-sciences-ltd , Institutional-trading-of-roivant-sciences , Insider-activity-at-roivant-sciences , Goldman-sachs-group , Securities-exchange-commission , Norges-bank

HC Wainwright Reaffirms "Buy" Rating for Roivant Sciences (NASDAQ:ROIV)

HC Wainwright Reaffirms "Buy" Rating for Roivant Sciences (NASDAQ:ROIV)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Eric-venker , Corton-capital-inc , News-ratings-for-roivant-sciences-daily , Morgan-stanley , Citigroup-inc , Roivant-sciences-stock-performance , Securities-exchange-commission , Deutsche-bank-aktiengesellschaft , Roivant-sciences-ltd , Goldman-sachs-group

Truist Financial Reaffirms "Buy" Rating for Roivant Sciences (NASDAQ:ROIV)

Truist Financial reiterated their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research report released on Monday, Benzinga reports. Truist Financial currently has a $23.00 price objective on the stock. A number of other research analysts have also recently issued reports on ROIV. TheStreet raised shares of Roivant Sciences from […]

United-states , America , American , Vivek-ramaswamy , Eric-venker , Nasdaq , Blackrock-inc , Securities-exchange-commission , Citigroup-inc , Roivant-sciences-stock-performance , News-ratings-for-roivant-sciences-daily , York-mellon-corp

Roivant Sciences Ltd. (NASDAQ:ROIV) Stock Holdings Lifted by Deerfield Management Company L.P. Series C

Deerfield Management Company L.P. Series C raised its position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 18.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,604,487 shares of the company’s stock after acquiring an additional 249,513 shares during […]

Piper-sandler , Eric-venker , Vivek-ramaswamy , Roivant-sciences-ltd , Deutsche-bank-aktiengesellschaft , Securities-exchange-commission , Blackrock-inc , Quarter-for-roivant-sciences , Roivant-sciences-stock-performance , Nasdaq , Roivant-sciences , Deerfield-management-companylp-series

Wolfe Research Begins Coverage on Roivant Sciences (NASDAQ:ROIV)

Wolfe Research started coverage on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research note published on Thursday, Marketbeat reports. The brokerage issued an outperform rating and a $17.00 price target on the stock. A number of other equities analysts have also recently commented on ROIV. Deutsche Bank Aktiengesellschaft started coverage on shares […]

United-states , America , Piper-sandler , Vivek-ramaswamy , Eric-venker , Roivant-sciences , Jpmorgan-chase-co , Deutsche-bank-aktiengesellschaft , News-ratings-for-roivant-sciences-daily , Roivant-sciences-ltd , Blackrock-inc , Wolfe-research

Roivant Sciences (NASDAQ:ROIV) Price Target Cut to $17.00 by Analysts at HC Wainwright

Roivant Sciences (NASDAQ:ROIV – Get Free Report) had its target price reduced by stock analysts at HC Wainwright from $18.00 to $17.00 in a research note issued on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 54.26% from the company’s […]

United-states , Canada , America , Eric-venker , Vivek-ramaswamy , Piper-sandler , Insider-transactions-at-roivant-sciences , Institutional-trading-of-roivant-sciences , Jpmorgan-chase-co , Allspring-global-investments-holdings , Roivant-sciences-company-profile , Headlands-technologies

Roivant Sciences Sees Unusually Large Options Volume (NASDAQ:ROIV)

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) saw unusually large options trading activity on Tuesday. Traders acquired 8,333 call options on the company. This represents an increase of 169% compared to the average daily volume of 3,098 call options. Insiders Place Their Bets In other Roivant Sciences news, major shareholder Svf Investments (Uk) Ltd […]

United-states , American , Keiths-manchester , Securities-exchange-commission , York-mellon-corp , Roivant-sciences-stock-performance , Cantor-fitzgerald , Citigroup-inc , Vanguard-group-inc , Roivant-sciences , Svf-investments-uk-ltd

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $14.71 Average Price Target from Analysts

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $14.71 Average Price Target from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , China , America , Eric-venker , Mitsubishi-ufj , Roivant-sciences , Analyst-recommendations-for-roivant-sciences , Roivant-sciences-ltd , Daiwa-securities-group-inc , Kokusai-asset-management-co , China-universal-asset-management-co , Institutional-trading-of-roivant-sciences

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 16,397 Shares

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Eric Venker Sells 16,397 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Blackrock , New-zealand-general- , New-zealand , Wellington , America , Eric-venker , Jpmorgan-chase-co , News-ratings-for-roivant-sciences-daily , Roivant-sciences-stock-performance , Roivant-sciences , Nasdaq

Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells $194,468.42 in Stock

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 16,397 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $11.86, for a total transaction of $194,468.42. Following the completion of the sale, the chief operating officer now directly […]

China , United-states , America , Eric-venker , Hedge-funds-weigh-in-on-roivant-sciences , Roivant-sciences-stock-performance , Cantor-fitzgerald , Roivant-sciences-ltd , Nasdaq , Jpmorgan-chase-co , Kokusai-asset-management-co , China-universal-asset-management-co